0001493152-21-025348.txt : 20211013
0001493152-21-025348.hdr.sgml : 20211013
20211013190846
ACCESSION NUMBER: 0001493152-21-025348
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211011
FILED AS OF DATE: 20211013
DATE AS OF CHANGE: 20211013
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: O'Malley Brendan M.
CENTRAL INDEX KEY: 0001884342
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15771
FILM NUMBER: 211322172
MAIL ADDRESS:
STREET 1: 1330 AVENUE OF THE AMERICAS
STREET 2: 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC.
CENTRAL INDEX KEY: 0000318306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 830221517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 646-813-4701
MAIL ADDRESS:
STREET 1: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
FORMER COMPANY:
FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC
DATE OF NAME CHANGE: 20140922
FORMER COMPANY:
FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960209
FORMER COMPANY:
FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0306
4
2021-10-11
0
0000318306
ABEONA THERAPEUTICS INC.
ABEO
0001884342
O'Malley Brendan M.
1330 AVENUE OF THE AMERICAS, 33RD FLOOR
NEW YORK
NY
10019
0
1
0
0
SVP, General Counsel
Common stock
2021-10-11
4
S
0
25734
0.9043
D
222510
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan
adopted by Brendan O'Malley on February 24, 2021.
The price reported in Column 4 is a weighted average price. The shares were
sold in multiple transactions at prices ranging from $0.89 to $0.9625, inclusive.
The reporting person undertakes to provide to the Issuer, any security holder,
or the Staff of the SEC, upon request, full information regarding the number of
shares disposed at each separate price within the ranges set forth in this
footnote.
/s/ Brendan O'Malley
2021-10-13